ScholarWorks@Hanyang University: Yoon, Ho Joo

Detailed Information

Yoon, Ho Joo (윤호주)

서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)

Research Area: 호흡기알레르기내과

Tel 02-2290-8349
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Asthma:26||asthma:13||epidemiology:7||bronchiectasis:5||COVID19:4||Air pollution:4||mortality:4||exhaled nitric oxide:3||Carcinoma:3||IL1Ra:3||Colchicine:3||chronic obstructive pulmonary disease:3||Paragonimiasis:3||Lung neoplasms:3||Korea:3||Bronchiectasis:3||Allergic rhinitis:3||airway inflammation:2||COPD:2||allergic rhinitis:2||Epidemiology:2||reference value:2||Scrub typhus.:2||registry:2||Etiology:2||genetic polymorphism:2||Severe asthma:2||Cystic:2||hepatitis:2||risk:2||Exhaled nitric oxide:2||risk factors:2||Interstitial lung disease:2||severe asthma:2||Smoking cessation:2||Cisplatin:2||biomarker:2||Climate change:2||Kidney failure:2||Leptospirosis:2||Diffusing capacity.:2||lung cancer:2||Thymoma.:2||treatment:2||tuberculosis:2||mannitol:2||Lung cancer:2||vaccine:2||MAPK.:2||Lung volume:2||Tuberculosis:2||Tuberculous pleurisy.:2||Cluster analysis:2||Prognosis:2||cluster analysis:2||Malignant effusion:2||Massive pleural effusion:2||Atopic dermatitis:2||Acute exacerbation:2||Mortality:2||Reference equation:2||disease severity:2||pneumonia:2||Multiple Pulmonary Nodules:2||Ectopic:2||Antituberculosis drugs:2||Characteristics:2||population:2||exacerbation:2||prevalence:2||Emergency department visit:2||Drugs:1||Ecadherin:1||EVALI:1||Elderly:1||Electronic cigarettes:1||Embolization, therapeutic:1||Eosinophils:1||Exercise:1||Extended RRS:1||FDG PET:1||Fat embolism syndrome:1||Fat globules:1||Fibromatosis:1||Forced expiratory volume:1||Genetic polymorphism:1||Glutathione Stransferase enzyme:1||H. pylori vacuolating cytotoxin:1||HL301:1||Hemoptysis:1||Hepatotoxicity:1||Histology:1||Humanized:1||Hypersensitivity:1||Immunocompetence:1||Implementation:1||Indoor air:1||Indoor air quality:1||Influenza B virus:1||Inhalant allergen:1||Interleukin10:1||Interleukin4 receptor alpha:1||Invasive pulmonary aspergillosis:1||Iron:1||Leukemia:1||Lung Disease:1||Lung epithelial cells:1||Lymphocytic:1||Lymphocytic interstitial pneumonia:1||MAPK:1||Maculopapular eruption:1||Mexiletine:1||Monoclonal:1||NIOX MINO:1||NOA280i:1||Nasal nitric oxide:1||Neoplasm metastasis, kidney:1||Never smoker:1||Nicotine:1||Nitirc oxide:1||Nitric oxide:1||NonSmall Cell Lung:1||NonSmallCell Lung:1||Nonsmall Cell Lung:1||Nuclearfactor kappa B:1||Obesity:1||Paint:1||Paraproteinemias:1||Parasitic lung diseases:1||Peak expiratory flow rate:1||Pharmacogenetics:1||Phenotypes:1||Plasmacytoma:1||Polymorphism:1||Porous microparticles:1||PositronEmission Tomography:1||Prevalence:1||Principal components analysis:1||Pulmonary Atelectasis:1||Pulmonary Eosinophilia:1||Pulmonary delivery:1||Questionnaires:1||RANTES:1||Rabies virus glycoprotein:1||Rapid Response System:1||Real world:1||Recurrence:1||Registries:1||Respiratory allergic diseases:1||Respiratory allergy:1||Rheumatoid:1||Rheumatoid arthritis:1||Rhinovirus:1||Risk:1||SABA:1||Sarcoidosis:1||Secondhand smoke:1||Severe eosinophilic asthma:1||Skin Test:1||Small Cell Lung Carcinoma:1||Smokers:1||Specific IgE:1||Stomach Neoplasms:1||Sudden:1||Surveys:1||Symbicort (R) maintenance and reliever therapy:1||Systemic sclerosis:1||Th2 responses:1||Thorax:1||Tolllike receptor4:1||Toxicology:1||Trajectory:1||Transforming growth factor beta1:1||Tumor Necrosis Factoralpha:1||Turbuhaler:1||Umckamin:1||Upper Extremity Deep Vein Thrombosis:1||Uterine leiomyoma:1||Vaccination:1||Wnt/betacatenin pathway:1||Wnt7a:1||acute bronchitis:1||acute exacerbation:1||adhesion:1||adipokines:1||adiposederived hormones:1||adiposity:1||adults:1||adverse reaction:1||adverse reactions:1||age:1||air pollution:1||allergens:1||animal model:1||antibody:1||antioxidants:1||antituberculosis drugs:1||artificial intelligence:1||aspirin:1||asthma exacerbation:1||asthmaCOPD overlap:1||asthmachronic obstructive pulmonary disease overlap syndrome:1||atopy:1||bleomycin:1||body mass index:1||bronchial hyperresponsiveness:1||bronchial provocation test:1||bronchitis severity score:1||budesonide:1||burden:1||chest CT:1||chronic urticaria:1||classification:1||clinical trial:1||cohort study:1||coinfection:1||cooking:1||coronavirus disease 2019:1||corticosteroid:1||cost:1||cough:1||crosssectional studies:1||death:1||dementia:1||dendritic cells:1||dermatomyositis:1||desquamative interstitial pneumonia:1||diagnosis:1||diagnostic test:1||economic:1||education:1||energy ratio:1||environmental pollution:1||eupatilin:1||financial:1||fishes:1||fixeddose combination:1||food allergy:1||forced expiratory flow between 25% and 75% of vital capacity:1||formoterol:1||gastroesophageal reflux:1||gender:1||guideline:1||healthcare workers:1||highaffinity IgE receptor:1||hypersensitivity:1||indoor:1||infection:1||inflammatory myopathy:1||influenza:1||intensive care units:1||intercellular adhesion molecule1:1||internal medicine:1||interstitial lung disease:1||irritable bowel syndrome:1||levocetirizine:1||lipocalin2:1||long shortterm memory:1||loudness:1||machinelearning:1||macrolide:1||meat:1||metered dose inhaler:1||methacholine:1||montelukast:1||multiplex polymerase chain reaction:1||multisystem inflammatory syndrome:1||myositis:1||nasal nitric oxide:1||nitric oxide:1||nitric oxide analyzer:1||nonsmall cell lung cancer (NSCLC):1||nontuberculosis mycobacterium:1||nuclear factor?B:1||obesity:1||outcome:1||oxidative stress:1||particulate matter:1||perception:1||phenotype:1||physical activity:1||pollution:1||polygammaglutamic acid:1||polymorphism:1||polymyositis:1||position paper:1||prescription:1||prescription drug overuse:1||prolonged cough:1||public health:1||pulmonary:1||pulmonary fibrosis:1||pulmonary tuberculosis:1||questionnaire survey:1||questionnaires:1||reference values:1||residents:1||respiratory failure:1||respiratory virus:1||rheumatic diseases (RDs):1||rheumatoid arthritis (RA):1||risk factor:1||sedentary behavior:1||sensitivity:1||serositis:1||sex:1||siRNA:1||siRNA delivery:1||sinusitis:1||skin prick test:1||small cell lung cancer (SCLC):1||smoking:1||specificity:1||steroids:1||superoxide dismutase:1||survival:1||symptom burden:1||tension pneumothorax:1||treatment outcome:1||tuberculosis (TB):1||tumour necrosis factora:1||upper airway cough syndrome:1||vaccination:1||vascular cell adhesion molecule 1:1||vascular dementia:1||급성 악화:1||대기오염:1||시스플라틴:1||신독성:1||응급실방문:1||천식:1||A549 cell:1||폐암:1||ABPM:1||Abnormalities:1||Acute kidney injury:1||Acute respiratory failure:1||Adult:1||Adverse cutaneous reactions:1||Adverse drug reactions:1||Aged:1||Aggressive:1||Airway hyperresponsiveness:1||Airway inflammation:1||Allergen:1||Allergic bronchopulmonary:1||Allergic disease:1||Alternaria alternate:1||Alzheimer disease:1||Anaphylaxis:1||AntiTB drugs:1||Antibodies:1||Antioxidants:1||Antiphospholipid Syndrome:1||Antitubercular agents:1||Apoptosis:1||Arthritis:1||AsiaPacific:1||Aspirinintolerant asthma:1||Asthma control test:1||AtRisk Patient:1||Atopy:1||BCell:1||Beas2B cell:1||Benign metastasizing leiomyomatosis (BML):1||Benzopyrene:1||Biologic Markers:1||Biological products:1||Biologics:1||Bronchi:1||Bronchial arteries:1||Bronchial hyperreactivity:1||Bronchoalveolar lavage:1||Bronchopleural fistula:1||Budesonide:1||Ckit (CD117):1||COVID19 infection:1||Cancer screening:1||Carcinoma, squamous cell:1||Cardiac:1||Cardiovascular diseases:1||ChAdOx1 nCoV19 vaccine:1||Chronic:1||Chronic expanding hematoma:1||Chronic obstructive pulmonary disease:1||Clinical characteristics:1||Cluster Analysis:1||Cohort:1||Computational Biology:1||Contrast media:1||Control:1||Corticosteroids:1||Cotinine:1||Cryptogenic organizing pneumonia:1||Cutaneous infection:1||Cystic adenomatoid malformation of lung, Congenital:1||Death:1||Dental Technicians:1||Disease prevention:1||Diskus:1||Drug Hypersensitivity:1||Druginduced liver injury:1||Drugmetabolizing enzymes:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE